ERBB2 and cancer: Finally, we tested the response of cells to two of the Her2 inhibitors, namelyAG825, a selective Her2 inhibitor and Neratinib a broad spectrum Her2 inhibitor used in cancer treatment (Figure 7A,B, Table 10).